Abstract
Respiratory infectious diseases had happened in China in recent years, and the outbreak of Corona Virus Disease 2019(COVID-19) had drawn worldwide attention. In order to control such high-mortality infectious diseases, the work of the Chinese government and the medical community in detection reagents, drugs, and vaccines had been speeded up. This research extensively searched the medical data of drugs, vaccines and kits development, the company's business report and the government's policy documents and conducted case analysis. We found some national mobilization measures had been put on the agenda and some special marketing authorization measures had been adopted. Due to the limitations of biotechnology research and the pharmaceutical industry, some key technologies and drugs still had a high external dependence. In the process of development, it was necessary to attach importance to scientific, ethical, and safety construction, and to strengthen international cooperation.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
